Irritable Bowel Syndrome (Diarrhea) - Chicago IL (Clinical Trial # 9817)
| City: |
|
Chicago |
| State: |
|
IL |
| Zip Code: |
|
60622 |
| Study summary: |
|
A 12-week, randomized, double-blind, placebo-controlled study of asimadoline in subjects with diarrhea-predominant irritable bowel syndrome. |
| Qualified participants must: |
|
• Be 18-79 years of age
•
Have IBS-Diarhhea symptoms for at least 6 months before enrolling in the study
|
| Participants may receive: |
|
Trial medications and investigations at no cost, and compensation for time and travel. |
| Study is available at: |
|
Illiniois Center for Clinical Research
1044 N. Mozart
Suite #500
Chicago, Illinois 60622
View Clinic Location
If you meet the above criteria and live within 50 miles of this clinic please enter your information below and click "I Am Interested In This Study" to be contacted by the study coordinator.
or
Click "View Contact Phone Number" to get the clinic's phone number.
|
| Phone number: |
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.